Mega Lifesciences PCL
SET:MEGA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mohawk Industries Inc
NYSE:MHK
|
US |
Mega Lifesciences PCL
Cash from Operating Activities
Mega Lifesciences PCL
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
Cash from Operating Activities
฿2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
B
|
Bangkok Lab and Cosmetic PCL
SET:BLC
|
Cash from Operating Activities
฿187.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Mega Lifesciences PCL
Glance View
Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.
See Also
What is Mega Lifesciences PCL's Cash from Operating Activities?
Cash from Operating Activities
2.8B
THB
Based on the financial report for Dec 31, 2025, Mega Lifesciences PCL's Cash from Operating Activities amounts to 2.8B THB.
What is Mega Lifesciences PCL's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
16%
Over the last year, the Cash from Operating Activities growth was 15%. The average annual Cash from Operating Activities growth rates for Mega Lifesciences PCL have been 12% over the past three years , 11% over the past five years , and 16% over the past ten years .
